Glomerular MYH9 expression is reduced by HIV-1

AIDS

Volumn 26, Issue 7, 2012, Pages 797-803

  Hays, Thomas ^a   D'Agati, Vivette D ^b   Garellek, Jonathan A ^a   Warren, Tjani ^a   Trubin, Marc E ^a   Hyink, Deborah P ^c   He, John Cijiang ^a   Klotman, Paul E ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Department of Pathology ^*  (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

focal segmental glomerulosclerosis; glomerulus; heavy chain 9 gene (MYH9); HIV 1; HIV associated nephropathy; myosin; podocyte

Indexed keywords

MYH9 PROTEIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GLOMERULOSA CELL; HIV ASSOCIATED NEPHROPATHY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE; KIDNEY; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

AIDS-ASSOCIATED NEPHROPATHY; ANIMALS; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HIV-1; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS; NONMUSCLE MYOSIN TYPE IIA; PODOCYTES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84859946262     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328351f6cf     Document Type: Article

References (25)

1. Wyatt CM, Morgello S, Katz-Malamed R, Wei C, Klotman ME, Klotman PE, et al. The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int 2009; 75:428-434.
2. Kaufman L, Collins SE, Klotman PE. The pathogenesis of HIVassociated nephropathy. Adv Chronic Kidney Dis 2009; 17:36-43.
3. Wyatt CM, Klotman PE, D'Agati VD. HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy. Semin Nephrol 2008; 28: 513-522.
4. Arendse CG, Wearne N, Okpechi IG, Swanepoel CR. The acute, the chronic and the news of HIV-related renal disease in Africa. Kidney Int 2010; 78:239-245.
5. Singh N, Nainani N, Arora P, Venuto RC. CKD in MYH9-related disorders. Am J Kidney Dis 2009; 54:732-740.
6. Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR. Nonmuscle myosin II takes centre stage in cell adhesion and migration. Nature Rev 2009; 10:778-790.
7. Seri M, Cusano R, Gangarossa S, Caridi G, Bordo D, Lo Nigro C, et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. Nat Genet 2000; 26:103-105.
8. Babayeva S, Miller M, Zilber Y, El Kares R, Bernard C, Bitzan M, et al. Plasma from a case of recurrent idiopathic FSGS perturbs nonmuscle myosin IIA (MYH9 protein) in human podocytes. Pediatr Nephrol 2011; 26:1071-1081.
9. Johnstone DB, Zhang J, George B, Leon C, Gachet C, Wong H, et al. Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy. Molec Cell Biol 2011; 31:2162-2170.
10. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008; 40:1175-1184.
11. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008; 40:1185-1192.
12. Nelson GW, Freedman BI, Bowden DW, Langefeld CD, An P, Hicks PJ, et al. Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. Hum Mol Genet 2010; 19:1805-1815.
13. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329:841-845.
14. O'SeaghdhaCM, Parekh RS,Hwang SJ, Li M, Kottgen A, Coresh J, et al. The MYH9/APOL1 region and Chronic Kidney Disease in European-Americans. Hum Mol Genet 2011; 20:2450-2456.
15. Kopp JB, Winkler CA, Nelson GW. MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing? Semin Nephrol 2010; 30:409-417.
16. Pattaro C, Aulchenko YS, Isaacs A, Vitart V, Hayward C, Franklin CS, et al. Genome-wide linkage analysis of serum creatinine in three isolated European populations. Kidney Int 2009; 76:297-306.
17. Dickie P, Felser J, Eckhaus M, Bryant J, Silver J, Marinos N, Notkins AL. HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 1991; 185:109-119.
18. Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Dickie P, Marinos NJ, et al. Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci USA 1992; 89:1577-1581.
19. Schwartz EJ, Cara A, Snoeck H, Ross MD, Sunamoto M, Reiser J, et al. Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes. J Am Soc Nephrol 2001; 12:1677-1684. (Pubitemid 32674430)
20. Saleem MA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 2002; 13:630-638. (Pubitemid 34183927)
21. Rosenstiel PE, Gruosso T, Letourneau AM, Chan JJ, LeBlanc A, Husain M, et al. HIV-1 Vpr inhibits cytokinesis in human proximal tubule cells. Kidney Int 2008; 74:1049-1058.
22. Papeta N, Chan KT, Prakash S, Martino J, Kiryluk K, Ballard D, et al. Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression. J Clin Investig 2009; 119:1178-1188.
23. Sekine T, Konno M, Sasaki S, Moritani S, Miura T, Wong WS, et al. Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease. Kidney Int 2010; 78:207-214.
24. Ghiggeri GM, Caridi G, Magrini U, Sessa A, Savoia A, Seri M, et al. Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome). Am J Kidney Dis 2003; 41:95-104. (Pubitemid 36043356)
25. Wei CC, Lalwani AK, Mhatre AN. In vitro expression and characterization of MYH9 mutant alleles linked to hereditary hearing loss. Otolaryngol Head Neck Surg 2010; 142:699-703.